Assignment of Assignor's Interest

Recorded: 2021-05-20 Pages: 19

Assignors

BROWN, CHRISTOPHER

Executed: 2021-04-28

FOSTER, DONALD

Executed: 2021-03-15

NAIR, JAYAPRAKASH K.

Executed: 2021-04-16

CHARISSE, KLAUS

Executed: 2021-04-13

JAYARAMAN, MUTHUSAMY

Executed: 2020-10-26

MILSTEIN, STUART

Executed: 2020-10-17

MATSUDA, SHIGEO

Executed: 2021-04-14

KEL'IN, ALEXANDER V.

Executed: 2021-04-30

THEILE, CHRISTOPHER

Executed: 2021-04-28

SEHGAL, ALFICA

Executed: 2021-01-15

MAIER, MARTIN A.

Executed: 2020-10-20

MANOHARAN, MUTHIAH

Executed: 2020-10-06

RAJEEV, KALLANTHOTTATHIL G.

Executed: 2020-06-05

JADHAV, VASANT R.

Executed: 2020-09-09

SCHLEGEL, MARK K.

Executed: 2021-04-13

JANAS, MAJA

Executed: 2021-04-14

Assignee

ALNYLAM PHARMACEUTICALS, INC.

300 THIRD STREET, THIRD FLOOR, CAMBRIDGE, MASSACHUSETTS, 02142

Covered Property (1)

Modified Rna Agents with Reduced Off-Target Effect

Patent: 11,504,391 →

Application: 16/461,523 →

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.